A phase I/II study of chemoradiation with oxaliplatin and 5-FU [fluorouracil] for locally advanced pancreatic cancer
Phase of Trial: Phase I/II
Latest Information Update: 08 Dec 2015
At a glance
- Drugs Oxaliplatin (Primary) ; Fluorouracil
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 04 Dec 2015 Status changed from active, no longer recruiting to discontinued, according to ClinicalTrials.gov record.
- 15 Apr 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 07 May 2014 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.